From October 1, 2022 to December 31, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 5,260,910 shares, representing 0.9% for CNY 243.27 million under the buyback announced on March 19, 2022.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55.85 CNY | -1.95% | -2.05% | -2.03% |
04-19 | Autobio Diagnostics' Q1 Profit Jumps 34% | MT |
04-19 | Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.03% | 4.58B | |
-1.29% | 12.64B | |
-0.47% | 8.37B | |
+5.68% | 5.37B | |
+22.61% | 5.26B | |
-53.56% | 3.16B | |
+19.30% | 2.89B | |
-8.42% | 2.22B | |
-3.55% | 1.91B | |
+5.37% | 1.65B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.